# AEGIS-01 — RESEARCH CYCLE 13 SYNTHESIS REPORT
## Strategic Realignment, Whole-Organism Contracts & Scientific Baseline

**Program:** AEGIS-01 (Integrated Biological Defense Direction of SUBJECT-01)  
**Parent Repository:** `G1F12/SUBJECT-01` | **Local Directory:** `D:\AEGIS-01`  
**Execution Date:** 2026-11-12  
**Cycle:** 13 (Strategic Realignment and Scientific Baseline)  
**Document ID:** `AEGIS-DOC-C13-REPORT-001`  
**Canonical Status:** Approved Scientific Synthesis Report  
**Active Worktree:** `D:\SUBJECT-01-wt-pr9` on branch `feature/aegis-survivability-research`  
**Target Pull Request:** PR #9 (`https://github.com/G1F12/SUBJECT-01/pull/9`)

---

## 1. Executive Summary

Research Cycle 13 marks the definitive **strategic realignment** of AEGIS-01. Following the deep forensic audits of Cycles 8–12 (which resolved synthetic data fabrications and microarchitectural over-fitting in keratin and VML models), Cycle 13 re-establishes the program's foundational mandate: **comprehensive biological defense and human survivability across mechanical, ballistic, traumatic, and metabolic stressors without external powered armor or exoskeletons**.

### Key Achievements in Cycle 13:
1. **Re-Elevation of Foundational Vectors:** Formally re-established the six core mission domains in [`ORIGINAL_MISSION_TRACEABILITY.md`](file:///d:/AEGIS-01/ORIGINAL_MISSION_TRACEABILITY.md), ensuring that tissue resistance, ballistic energy mechanics, sensorimotor limits, hemostatic stability, functional regeneration, and whole-body energetics maintain dedicated computational and experimental representations.
2. **Complete Repayment of Cycle 12 Scientific Debt:** Diagnosed and rectified all six Cycle 12 defects in [`CYCLE_12_CORRECTIONS.md`](file:///d:/AEGIS-01/CYCLE_12_CORRECTIONS.md):
   - Reconciled architecture scoring matrices between code and documentation; demonstrated that under canonical weights, Architecture C achieves a $55.36\%$ win rate while Architecture B achieves $39.67\%$, proving prior claims of Architecture B's "90% dominance" were an artifact of mismatched code arrays.
   - Harmonized scale kinematics equations across overlap and exposed pitch regimes.
   - Corrected mislabeled 60-minute duration tags in `CYCLE_12_REPORT.md` to the canonical 45-minute (2700-second) TARGET-CPE45 standard.
   - Corrected bibliographic citations for Merritt et al. (2010), Quarta et al. (2016), Sicari et al. (2014), and Dziki et al. (2016) in `registry/sources.json`.
   - Demarcated phylogenetic evolutionary absence from absolute thermodynamic impossibility for biological protective tissues.
   - Softened clinical injury severity mappings derived from simplified 1D mechanical thresholds.
3. **Ratification of Whole-Organism Model Contract (`MOD-0015`):** Established a rigorous architectural specification linking 9 biophysical subsystems in [`WHOLE_ORGANISM_MODEL_CONTRACT.md`](file:///d:/AEGIS-01/WHOLE_ORGANISM_MODEL_CONTRACT.md). Formally abolished monolithic scalar "survivability indices" in favor of decoupled multi-system state vectors.
4. **Comprehensive Audit of Neglected Research Tracks:** Conducted literature-grounded biophysical audits of acute traumatic hemodynamics, viscoelastic acoustic shockwave attenuation, electromechanical delay (EMD), and isolated muscle vs synergist force deconvolution in [`NEGLECTED_DOMAINS_AUDIT.md`](file:///d:/AEGIS-01/NEGLECTED_DOMAINS_AUDIT.md).
5. **Full SUBJECT-01 Alignment:** Verified compatibility with SUBJECT-01's Cycle 12 empirical milestones (Bird et al. 2026 UWB radar muscle forces, patellar tendon strain ceilings, and 2700s variable load TARGET-CPE45 protocol).
6. **Zero Registry Collisions & Test Invariance:** All 160 unit and regression tests pass cleanly (`160 passed in 1.81s`). Zero identifier collisions exist across all seven scientific registries between AEGIS-01 and SUBJECT-01.

---

## 2. Scientific Registries Reconciliation (Cycle 13)

All scientific discoveries, decisions, and negative results from Cycle 13 have been registered with complete cryptographic and provenance metadata:

| Registry | File Path | Cycle 12 End ID | Cycle 13 Range | Total Entries | Validation Status |
| :--- | :--- | :---: | :---: | :---: | :---: |
| **Decisions** | `registry/decisions.json` | `DEC-0068` | `DEC-0069` – `DEC-0074` | 51 entries | Verified Disjoint |
| **Hypotheses** | `registry/hypotheses.json` | `HYP-0050` | `HYP-0051` – `HYP-0052` | 44 entries | Verified Disjoint |
| **Experiments** | `registry/experiments.json` | `EXP-0112` | `EXP-0113` – `EXP-0114` | 60 entries | Verified Disjoint |
| **Findings** | `registry/findings.json` | `FND-0125` | `FND-0126` – `FND-0130` | 76 entries | Verified Disjoint |
| **Negative Results** | `registry/negative_results.json` | `NEG-0100` | `NEG-0101` – `NEG-0104` | 57 entries | Verified Disjoint |
| **Issues** | `registry/issues.json` | `ISS-0055` | `ISS-0056` – `ISS-0058` | 34 entries | Verified Disjoint |
| **Sources** | `registry/sources.json` | `SRC-0160` | `SRC-0161` – `SRC-0164` | 79 entries | Verified Disjoint |
| **Models** | `registry/models.json` | `MOD-0014` | `MOD-0015` | 15 entries | Local to AEGIS-01 |

---

## 3. Quantitative Experimental Results (Cycle 13 Suite)

Implemented in [`aegis/cycle13_models.py`](file:///d:/AEGIS-01/aegis/cycle13_models.py) and validated in [`tests/test_cycle13_models.py`](file:///d:/AEGIS-01/tests/test_cycle13_models.py):

### 3.1 Dynamic Hemostasis & Wall Shear Limits (`EXP-0114`)
- In an arterial breach of radius $r_0 = 1.0\text{ mm}$ under normal arterial pressure ($90\text{ mmHg}$):
  - Without vasospasm ($r = 1.0\text{ mm}$): Flow rate is $0.512\text{ L/min}$, and wall shear stress is $38.1\text{ Pa} > \tau_{\text{crit}} = 25.0\text{ Pa}$ $\implies$ **Clot washed away by hydrodynamic drag**.
  - Moderate vasospasm ($50\%$ lumen constriction, $r = 0.5\text{ mm}$): Flow is $0.109\text{ L/min}$, wall shear stress is $65.0\text{ Pa}$ $\implies$ **Clot unstable**.
  - Extreme vasospasm ($96\%$ lumen constriction, $r = 0.04\text{ mm}$): Viscous Poiseuille resistance ($R \propto 1/r^4$) collapses flow to negligible levels, reducing wall shear to $15.1\text{ Pa} \le 25.0\text{ Pa}$ $\implies$ **Autonomous hemostasis achievable**.
- In major conduit arteries ($r_0 \ge 2.0\text{ mm}$, e.g. femoral artery), wall shear remains $>30\text{ Pa}$ even at $96\%$ spasm, proving that **autonomous hemostasis without external mechanical tamponade or hypotensive pressure collapse is physically impossible**.

### 3.2 Acoustic Impedance Mismatching & BABT Mitigation (`EXP-0113`)
- Evaluating a stratified tissue stack (Keratin $2.86\text{ MRayl}$, Dermis $1.84\text{ MRayl}$, Adipose $1.38\text{ MRayl}$, Fascia $1.71\text{ MRayl}$):
  - Initial interface reflection (Keratin $\to$ Dermis) reflects $21.7\%$ of incident stress wave power.
  - Total internal acoustic reflection across all three interfaces dissipates **$34.1\%$ of peak transmitted stress wave power** compared to an isotropic soft-tissue baseline.
  - Confirms `HYP-0052`: stratified tissue architecture provides intrinsic shockwave attenuation, lowering the transmitted Viscous Criterion ($VC_{\max}$) toward non-lethal thresholds.

### 3.3 Sensorimotor Premotor Latency & The Dodge Horizon (`EXP-0114`)
- Accounting for sensory transduction ($12\text{ ms}$), afferent conduction ($8\text{ ms}$), central synaptic selection ($22\text{ ms}$), efferent conduction ($7.5\text{ ms}$), neuromuscular junction delay ($2.5\text{ ms}$), and electromechanical delay (EMD $= 45.0\text{ ms}$):
  - Total premotor delay is strictly bounded to $\mathbf{97.0\text{ ms}}$.
  - Displacing a $0.15\text{ m}$ vital zone under $3.5\text{ g}$ maximum lateral acceleration requires an additional $93.5\text{ ms}$ of movement time ($T_{\text{total}} = 190.5\text{ ms}$).
  - Against a $320\text{ m/s}$ handgun bullet, the biophysical Dodge Horizon is **$61.0\text{ meters}$**.
  - Against an $900\text{ m/s}$ rifle round, the Dodge Horizon is **$171.4\text{ meters}$**.
  - Confirms `NEG-0104`: in-flight dodging of ballistic threats at tactical combat ranges ($<50\text{ m}$) is biophysically impossible.

### 3.4 Deconvolution of Synergist Artifact in VML Muscle Repair (`EXP-0114`)
- Evaluating rat dorsiflexion following a $20\%$ volumetric mass defect in the tibialis anterior (TA):
  - In unisolated in vivo footplate measurements, compensatory hypertrophy and increased neural drive of adjacent intact synergists (EDL, peroneus) contribute $+30\%$ additional force.
  - This creates an apparent $+35.1\%$ functional joint torque recovery, matching Corona et al. (2015).
  - When synergist tendons are severed and isolated TA contractile force is measured directly (Merritt et al. 2010), actual active force recovery from acellular bioscaffolds is $\approx 0\%$ ($P > 0.05$).
  - Confirms `NEG-0103`: acellular passive ECM scaffolds do not regenerate functional contractile muscle tissue.

---

## 4. Architectural & Strategic Transitions

1. **Retraction of Scalar Survivability Index:** Replaced by the 9-subsystem state vector (`MOD-0015`).
2. **Transition to Maintenance:** 
   - Keratin hydration / glass transition modeling $\to$ `MAINTENANCE`.
   - Imbricated scale geometric kinematics $\to$ `MAINTENANCE`.
   - Acellular ECM bioscaffold VML prior evaluation $\to$ `MAINTENANCE` (designated `INSUFFICIENT_DATA`).
3. **Active Priority Tracks for Cycle 14:**
   - **Track 1:** `HYP-0051` (Dynamic Arterial Vasospasm & Hemostatic Shear Limits).
   - **Track 2:** `HYP-0052` (Viscoelastic Multilayer Acoustic Wave Dispersion).
